GlobalData on MSN1d
Junshi partners LEO Pharma for toripalimab distribution in Europe
Junshi Biosciences and TopAlliance are set to enter a collaboration with LEO Pharma to distribute and market toripalimab in ...
FiercePharma1d
Leo bags EU rights to Junshi's Loqtorzi, putting marketing muscle behind PD-1 launch
Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of multiple malignant tumors. To date, toripalimab has been approved for marketing ...
Junshi Biosciences Announces Toripalimab’s Approval in Australia
General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...
經濟通ET Net1d
Summary of listed companies announcements (5)
01877 JUNSHI BIO Announcements and Notices - (Profit Warning / Inside Information) 01877 JUNSHI BIO Announcements and Notices - (Overseas Regulatory Announcement - Oth 01919 COSCO SHIP HOLD Next Day ...